English   español  

Navegación por Autor rp13808

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 47 a 64 de 64 < Anterior 
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
openAccessAbstract_Pérez de la Lastra_YRS_2021.pdf.jpg18-jun-2021P34 Measuring protein aggregation in lymphoblasts from als patients with a turbidometric assayPérez de la Lastra, C. CSIC; Tosat-Bitrian, Carlota CSIC ORCID ; Nozal, Vanesa CSIC ORCID; Martínez Gil, Ana CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Palomo, Valle CSIC ORCID comunicación de congreso
openAccessAbstract_Tosat-Bitrián_YRS_2021.pdf.jpg18-jun-2021P47 Biosensors and cellular models derived from patients: towards molecular characterization and personalized medicineTosat-Bitrian, Carlota CSIC ORCID ; Fernández, Paula; Martínez Gil, Ana CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Palomo, Valle CSIC ORCID comunicación de congreso
openAccess1-ago-2020Protein kinase inhibitors for amyotrophic lateral sclerosis therapyPalomo, Valle CSIC ORCID ; Nozal, Vanesa CSIC ORCID; Rojas-Prats, Elisa CSIC ORCID; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2013Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3Beurel, Eleonore; Kaidanovich-Beilin, Oksana; Yeh, Wen-I.; Song, Ling; Palomo, Valle CSIC ORCID ; Michalek, Suzane M.; Woodgett, James R.; Harrington, Laurie E.; Eldar-Finkelman, Hagit; Martínez Gil, Ana CSIC ORCID ; Jope, Richard S.artículo
openAccessde Munck_journal.pone_2016.pdf.jpg15-sep-2016Small GSK-3 inhibitor shows efficacy in a motor neuron disease murine model modulating autophagyDe Munck, E.; Palomo, Valle CSIC ORCID ; Muñoz-Sáez, E.; Pérez Fernández, Daniel Ignacio; Gómez-Miguel, Begoña; Solas, M. Teresa; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Arahuetes, Rosa Mªartículo
openAccessJ.Enz. Inhibit. Med. Chem. 2017.pdf.jpg23-ene-2017Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosaMarchena, Miguel CSIC; Villarejo-Zori, Beatriz CSIC ORCID ; Zaldívar-Díez, Josefa CSIC ORCID; Palomo, Valle CSIC ORCID ; Gil, Carmen CSIC ORCID ; Hernández-Sánchez, Catalina ; Martínez Gil, Ana CSIC ORCID ; De la Rosa, Enrique J. CSIC ORCID artículo
openAccessWO2011039403A1.pdf.jpg7-abr-2011Substituted 5-IMINO-1,2,4-THIADIAZOLES that can be used to treat neurodegenerative diseasesMartínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; Palomo, Valle CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Pérez, Concepción CSIC ORCID; Pérez Castillo, Ana CSIC ORCID; Loza, María Isabel; Cadavid, María Isabel; Brea, José Manuelsolicitud de patente
closedAccessaccesoRestringido.pdf.jpg2017Subtly modulating glycogen synthase kinase 3 ß: Allosteric inhibitor development and their potential for the treatment of chronic diseasesPalomo, Valle CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Roca, Carlos CSIC ORCID; Anderson, Cara; Rodríguez-Muela, Natalia; Pérez, Concepción CSIC ORCID; Morales-García, José A. CSIC ORCID; Reyes Rodríguez, Julio Alberto; Campillo, Nuria E. CSIC ORCID ; Pérez Castillo, Ana CSIC ORCID; Rubin, Lee L.; Timchenko, Lubov; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2011Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: Clues for specific design of new compoundsPérez, Daniel I. CSIC ORCID; Palomo, Valle CSIC ORCID ; Pérez, Concepción CSIC ORCID; Gil, Carmen CSIC ORCID ; Dans, Pablo D.; Luque Garriga, Francisco Javier; Conde, Santiago CSIC; Martínez Gil, Ana CSIC ORCID artículo
openAccessWO2023281149A1.pdf.jpg12-ene-2023Tau-tubulin kinase (TTBK) inhibitor compoundsMartínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; Nozal, Vanesa CSIC ORCID; Palomo, Valle CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Martínez-González, Loreto CSIC ORCID solicitud de patente
openAccess3-ene-2022TDP-43 modulation by Tau-Tubulin kinase 1 inhibitors: A new avenue for future amyotrophic lateral sclerosis therapyNozal, Vanesa CSIC ORCID; Martínez-González, Loreto CSIC ORCID ; Gómez-Almería, Marta; Gonzalo-Consuegra, Claudia; Santana, Paula; Chaikuad, Apirat; Cuevas, Eva P. CSIC ORCID ; Knapp, Stefan; Lietha, Daniel CSIC ORCID ; Ramírez, David; Petralla, Sabrina; Monti, B.; Gil, Carmen CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Palomo, Valle CSIC ORCID ; De Lago, E.; Martínez Gil, Ana CSIC ORCID artículo
openAccessbiomedicines_cuevas_2022.pdf.jpg5-feb-2022TDP-43 pathology and prionic behavior in human cellular models of Alzheimer’s disease patientsCuevas, Eva P. CSIC ORCID ; Rodríguez-Fernández, Alberto; Palomo, Valle CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID artículo
openAccessacs-cn_revised_2019.pdf.jpg20-mar-2019TDP-43: a key therapeutic target beyond amyotrophic lateral sclerosisPalomo, Valle CSIC ORCID ; Tosat-Bitrian, Carlota CSIC ORCID ; Nozal, Vanesa CSIC ORCID; Nagaraj, Siranjeevi; Martín-Requero, Ángeles CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo
openAccessnew iminothiadiazole derivative.pdf.jpg2012The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injurySusín, Cristina CSIC ORCID; Morales-García, José A. CSIC ORCID; Aguilar Morante, Diana CSIC ORCID; Palomo, Valle CSIC ORCID ; Sanz-SanCristóbal, Marina CSIC; Alonso-Gil, Sandra CSIC; Gil, Carmen CSIC ORCID ; Santos, Ángel; Martínez Gil, Ana CSIC ORCID ; Pérez Castillo, Ana CSIC ORCIDartículo
closedAccessaccesoRestringido.pdf.jpg2011The potential role of glycogen synthase kinase 3 inhibitors as Amyotrophic lateral sclerosis pharmacological therapyPalomo, Valle CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo
openAccessWO2022248395A1_Dystrophy.pdf.jpg1-dic-2022Thiadiazolidinones for their use in the treatment of limb-girdle muscular dystrophyMartínez Gil, Ana CSIC ORCID ; Palomo, Valle CSIC ORCID ; Sáenz Peña, Miren Ametsa; López de Munain, Adolfosolicitud de patente
openAccessEP4094760A1_Dystrophy.pdf.jpg30-nov-2022Thiadiazolidinones for their use in the treatment of limb-girdle muscular dystrophyMartínez Gil, Ana CSIC ORCID ; Palomo, Valle CSIC ORCID ; Sáenz Peña, Miren Ametsa; López de Munain, Adolfosolicitud de patente
openAccessFrontiers in Molecular Neuroscience_Martinez-Gonzalez_2023.pdf.jpg9-ago-2023TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patientsMartínez-González, Loreto CSIC ORCID ; Cuevas, Eva P. CSIC ORCID ; Tosat-Bitrian, Carlota CSIC ORCID ; Nozal, Vanesa CSIC ORCID; Gil, Carmen CSIC ORCID ; Palomo, Valle CSIC ORCID ; Martín-Requero, Ángeles CSIC ORCID ; Martínez Gil, Ana CSIC ORCID artículo